Differential diagnosis between complete and partial mole by TSSC3 antibody completely correlates to DNA diagnosis

Diagnostic Molecular Pathology

Volumn 14, Issue 3, 2005, Pages 164-169

  Kato, Hidenori ^a   Matsuda, Takao ^a   Hirakawa, Toshio ^a   Ueda, Kyoko ^a   Inoue, Takafumi ^a   Miyanari, Yoko ^a   Asanoma, Kazuo ^a   Nakano, Hitoo ^a   Wake, Norio ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Complete mole; Decorin; Imprinting gene; KCNQ1; Partial mole; TSSC3

Indexed keywords

DECORIN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA POLYMORPHISM; DOWN REGULATION; FERTILIZATION; GENE; GENE EXPRESSION; GENE REPRESSION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; INCIDENCE; KCNQ1 GENE; PRIORITY JOURNAL; SLC22A1L GENE; SPERM; TISSUE MICROARRAY; TSSC3 GENE; WESTERN BLOTTING; ZYGOTE;

ANTIBODIES; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANIC CATION TRANSPORT PROTEINS; POTASSIUM CHANNELS, VOLTAGE-GATED; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEOGLYCANS;

EID: 25844450189     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000162757.91649.a3     Document Type: Article

References (23)

1. Park WW. Choriocarcinoma: A Study of its Pathology. Philadelphia: Davis, 1971:55-58.
2. Berkowitz RS, Goldstein DP. Gestational trophoblastic disease. Cancer. 1995;76:2079-2085.
3. Jacobs PA, Angell RR, Buchanan IM, et al. The origin of human triploids. Ann Hum Genet. 1978;42:49-57.
4. Genest DR. Partial hydatidiform mole: Clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol. 2001;20:315-322.
5. Vejerslev LO. Clinical management and diagnostic possibilities in hydatidiform mole with coexistent fetus. Obstet Gynecol Surv. 1991;46:577-588.
6. Silverberg SG, Kurman RJ. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Washington, D.C.: Armed Forces Institute of Pathology; 1992:236-245.
7. Paradinas FJ, Browne P, Fisher RA, et al. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortus. Histopathology. 1996;28:101-109.
8. Fisher RA, Hodges MD. Genomic imprinting in gestational trophoblastic disease - A review. Placenta. 2003;17:S111-S118.
9. Kato HD, Terao Y, Ogawa M, et al. Growth-associated gene expression profiles by microarray analysis of trophoblast of molar pregnancies and normal villi. Int J Gynecol Pathol. 2002;21:255-260.
10. Ogawa O, Eccles MR, Szeto J, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 1993;362:749-751.
11. Arima T, Matsuda T, Takagi N, et al. Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet. 1997;93:39-47.
12. Thaker HM, Berlin A, Tycko B, et al. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med. 2004;49:630-636.
13. Frank D, Fortino W, Clark L, et al. Placental overgrowth in mice lacking the imprinted gene Ip1. Proc Natl Acad Sci USA. 2002;99:7490-7495.
14. Engemann S, Strodicke M, Paulsen M, et al. Sequence and functional comparison in the Beckwith-Wiedemann region: Implications for a novel imprinting centre and extended imprinting. Hum Mol Genet. 2000;9:2691-2706.
15. Pulkkinen L, Alitalo T, Krusius T, et al. Expression of decorin in human tissues and cell lines and defined chromosomal assignment of the gene locus (DCN). Cytogenet Cell Genet. 1992;60:107-111.
16. Ohyama M, Kojyo T, Gotoda H, et al. Mesenchymal dysplasia of the placenta. Pathol Int. 2000;50:759-764.
17. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest. 1998;78:269-276.
18. Jun SY, Ro JY, Kim KR. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology. 2003;43:17-25.
19. Castrillon DH, Sun D, Weremowicz S, et al. Discrimination of Complete Hydatidiform Mole From Its Mimics by Immunohistochemistry of the Paternally Imprinted Gene Product p57 KIP2. Am J Surg Pathol. 2001;25:1225-1230.
20. Fukunaga M. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. Hum Pathol. 2002;33:1188-1192.
21. Crisp H, Burton JL, Stewart R, et al. Refining the diagnosis of hydatidiform mole: Image ploidy analysis and p57KIP2 immunohistochemistry. Histopathology. 2003;43:363-373.
22. Varmuza S, Mann M. Genomic imprinting-defusing the ovarian time bomb. Trends Genet. 1994;10:118-123.
23. Wrzeska M, Rejduch B. Genomic imprinting in mammals. J Appl Genet. 2004;45:427-433.